US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. July 16, 2019

    Judge OKs Release Of National Opioid Sales Data

    The Ohio federal judge overseeing multidistrict litigation over the opioid crisis said that national data on opioid sales before December 2012 should be publicly available.

  2. July 16, 2019

    Pharmacy Benefit Cos. Improved Opioid Policies, Judge Says

    The nation's biggest pharmacy benefit management companies have voluntarily implemented policies to help clamp down on painkiller prescriptions, according to an Ohio federal judge overseeing multidistrict litigation over the opioid addiction epidemic.

  3. July 12, 2019

    Native American Cases To Watch In 2nd Half Of 2019

    Native American law practitioners will be keeping close tabs on the U.S. Supreme Court's reboot of a murder case with major implications for tribal jurisdiction in Oklahoma as well as on Fifth Circuit challenges to the Indian Child Welfare Act and the Affordable Care Act and the first trial in the massive opioid multidistrict litigation.

  4. July 03, 2019

    Product Liability Cases To Watch: Midyear Review

    For the rest of 2019, product liability attorneys will be closely following Oklahoma's case alleging Johnson & Johnson fueled the opioid epidemic and the litigation Boeing is facing after two fatal crashes involving its 737 Max 8 aircraft. Here, Law360 looks at those and other cases to watch in the second half of 2019.

  5. July 03, 2019

    The Biggest Legal Ethics Decisions Of 2019: Midyear Report

    During the first six months of 2019, the legal ethics arena saw a Tenth Circuit decision on judicial ethics complaints against U.S. Supreme Court Justice Brett Kavanaugh and the first of several potential rulings on conflicts in the “Varsity Blues” college admissions case. Here are some of the top legal ethics and malpractice decisions from the first half of the year.

  6. July 01, 2019

    Opioid MDL Litigants Seek Triumphs Before Bellwether Trial

    As a bellwether trial nears in multidistrict opioid litigation, drug companies and Ohio local governments are seeking victories on crucial legal questions over liability for a deadly addiction epidemic and a proposed multibillion-dollar remedy.

  7. June 25, 2019

    Opioid MDL Judge Seems Open To Novel Deal Approach

    The Ohio federal judge overseeing the opioid multidistrict litigation appeared receptive Tuesday to an inventive proposal to create a class of local governments to negotiate a global settlement with drug companies accused of fueling the addiction crisis, saying novel problems need novel solutions.

  8. June 24, 2019

    'Negotiating Class' Bid Slammed In Opioid MDL

    Drug distributors, pharmacies and state attorneys general on Monday launched a salvo against a novel bid by local governments in the opioid multidistrict litigation to create a "negotiating class" to seek a global settlement of claims that drug companies fueled the opioid crisis.

  9. June 21, 2019

    Biggest Health And Life Sci Rulings Of 2019: Midyear Report

    The first half of 2019 saw an extraordinary eruption of important court decisions likely to leave lasting marks on the opioid crisis, the False Claims Act, the Affordable Care Act and Medicare reimbursement. Here, Law360 takes stock of consequential health care and life sciences rulings that lawyers need to know.

  10. June 14, 2019

    3 Takeaways As 'Negotiation Class' Idea Jolts Opioid MDL

    An unconventional move Friday to resolve multidistrict opioid litigation by unifying local governments in a “negotiation class” could be an inflection point for the bruising legal slugfest targeting drug companies, although class certification isn’t a sure thing. Here, Law360 explores three key takeaways from the high-stakes maneuver.